🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this research study is to evaluate the safety and tolerability ...
Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2023-04-21
Trial ID
NCT05701488
Treatments Being Tested
Patients with intrahepatic cholangiocarcinoma (IHC) have relatively aggress...
Status
Recruiting
Location
Oslo University Hospital
Start Date
2024-02-13
Trial ID
NCT06313203
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab and yttrium Y 90 ibritu...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2003-11
Trial ID
NCT00070447
This study is being done to help doctors improve how they treat liver tumor...
Status
Not Yet Recruiting
Location
Northwestern University
Start Date
2026-05
Trial ID
NCT07586046
Treatments Being Tested
This clinical trial will be conducted as a single-center, open-label, Phase...
Status
Terminated
Location
University of Iowa Hospitals and Clinics
Start Date
2020-10-05
Trial ID
NCT04108481
Treatments Being Tested
The challenge of LDLT to HCC is that tumors with a high risk of recurrence ...
Status
Recruiting
Location
Department of Surgery
Start Date
2021-04-01
Trial ID
NCT06327269
Treatments Being Tested
Underlying disease mechanisms are fundamental for correct treatment selecti...
Status
Unknown
Location
Department of Radiology, IRCCS Ospedale San Raffaele
Start Date
2024-05-01
Trial ID
NCT06375915
Treatments Being Tested
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill the...
Status
Unknown
Location
Garden State Cancer Center
Start Date
2000-08
Trial ID
NCT00006458
Treatments Being Tested
This is a phase I dose escalation study (3+3 design) with a dose expansion ...
Status
Completed
Location
University of California San Francisco
Start Date
2017-01-09
Trial ID
NCT02602327
Treatments Being Tested
The aim of the study is to test \[90\]Y-ibritumomab tiuxetan, a radioactive...
Status
Completed
Location
Multiple Locations
Start Date
2001-08
Trial ID
NCT00185393
Treatments Being Tested